Skip to main content

Table 1 The treatment in KD patients with thrombosis in CAA

From: Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study

Patient

ID

Treatment at beginning

Thrombosis occurrence and treatment

ECG

Age

(y)

Time- Asp

(d)

Time- IVIG

(d)

IVIG dose

Time from KD onset

WBC

(×109)

PLT

(×109)

CRP

(mg/L)

Treatment Method

Duration to recover

Site

1

1st

6.5

16

16

2 g/kg

16d

12.8

505

126.8

2

10d

LAD

Normal

2nd

6.7

60

-

-

2 m

5.4

343

2.78

3

2 m

LAD

Normal

2

1st

6.5

9

9d/14d

4 g/kg

1 m

12.6

548

6.8

3

10d

Central RCA

Normal

2nd

8

9

8 m

2 g/kg

1.5y

4.37

289

5.7

3

> 2 m

Distal RCA

Abnormal

3

1st

1.5

13

13

2 g/kg

5.5

6.12

277

-

2

-

LAD

Normal

2nd

    

6.5y

4.31

302

1.9

3

8 m

LAD

Normal

4

3

15

16

2 g/kg

15d

5.59

521

39.7

3

10d

LM

Normal